Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Randomized Controlled Trial of Dietary Supplementation With Bifidobacterium Infantis NLS Super Strain Among Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms
INTERVENTIONAL
Inicio: 21 de jul de 2017
ID: NCT03271138
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 20 de abr de 2015
ID: NCT02293395
Completado
Fase 3
ClinicalTrials.gov
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
INTERVENTIONAL
Inicio: 11 de sept de 2013
ID: NCT01560637
Completado
ClinicalTrials.gov
COVID-19 Sequelae: Treatment and Monitoring of Persistent Symptoms, a Decentralized Approach Focus on the Patient. Use of Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A.
INTERVENTIONAL
Inicio: 22 de sept de 2021
ID: NCT05531019
Activo, no recluta
Fase 3
ClinicalTrials.gov
ZEUS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Participants With Established Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Systemic Inflammation
INTERVENTIONAL
Inicio: 30 de ago de 2021
ID: NCT05021835
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)
INTERVENTIONAL
Inicio: 1 de ene de 2002
ID: NCT00097786
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
INTERVENTIONAL
Inicio: 2 de mar de 2017
ID: NCT03057951
Completado
ClinicalTrials.gov
Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms. (CAC-TRAIT Study)
OBSERVATIONAL
Inicio: 7 de nov de 2022
ID: NCT05619042
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Multicentre, Randomised, Double-blind,Age-stratified, Placebo Controlled Phase III Study With an 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Patients With T2DM and Cardiovascular Disease, Who Exhibit Inadequate Glycaemic Control on Usual Care
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01042977
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function
INTERVENTIONAL
Inicio: 19 de dic de 2017
ID: NCT03315143
Completado
Fase 3
ClinicalTrials.gov
Long-term Single-arm Open-label Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 17 de oct de 2008
ID: NCT00667823
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319
INTERVENTIONAL
Inicio: 2 de may de 2019
ID: NCT03785405
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.
INTERVENTIONAL
Inicio: 11 de nov de 2010
ID: NCT01243424
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01663402
Terminado
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Heart Disease
INTERVENTIONAL
Inicio: 1 de feb de 2022
ID: NCT05147766
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Open-Label, Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Patients With HER2-Positive Early Breast Cancer
INTERVENTIONAL
Inicio: 14 de jun de 2018
ID: NCT03493854
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind 52-week Study to Evaluate the Safety and Efficacy of an LCZ696 Regimen Compared to an Olmesartan Regimen on Arterial Stiffness Through Assessment of Central Blood Pressure in Elderly Patients With Hypertension
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01692301
Completado
ClinicalTrials.gov
An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02082548
Completado
Fase 4
ClinicalTrials.gov
Phase IV, Multicenter, Double-blind, Randomized, Controlled, Parallel-group, Trial to Evaluate the Efficacy and Safety of Dozolamide 2%/Timolol 0,5% PF vs Dorzolamide 2%/Timolol 0,5% BAK-preserved in OAG or OH
INTERVENTIONAL
Inicio: 7 de mar de 2023
ID: NCT05857267
Terminado
Fase 4
ClinicalTrials.gov
A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging
INTERVENTIONAL
Inicio: 7 de jul de 2021
ID: NCT04435782
Anterior
1
...
36
37
38
...
434
Siguiente
Filtros